Metraipolis › archive › dc_e952d70cf797
Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients — Europe PMC PMID:42187563
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42187563
- DOI
- 10.3390/curroncol33050246
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T04:50:54.185Z
- SHA-256 of the archived text
8a1cc1cf7bf654dbaf99f51006205817532e1006b1f47615695231fb8996d350- Stable URL of this page
https://metraipolis.com/documento/dc_e952d70cf797
How to cite
Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients — Europe PMC PMID:42187563 — Europe PMC (en), https://europepmc.org/article/MED/42187563 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e952d70cf797 (Metraipolis archive dc_e952d70cf797, sha256 8a1cc1cf7bf654dbaf99f51006205817532e1006b1f47615695231fb8996d350)
BibTeX
@misc{dce952d70cf797,
title = {Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients — Europe PMC PMID:42187563},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42187563},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e952d70cf797; sha256 8a1cc1cf7bf654dbaf99f51006205817532e1006b1f47615695231fb8996d350},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42187563. Agents can read the archived copy with the MCP tool read_document.